GEN
Published in

GEN

Did the Costs of Pausing the J&J Vaccine Outweigh the Benefits?

Americans in states across the country started getting vaccinated with the Johnson & Johnson/Janssen Covid vaccine again yesterday, after regulators ended a suspension of the vaccine that had lasted almost two weeks. The FDA and the CDC decided to halt the use of the J&J vaccine on April 13 over concerns about a rare blood-clotting disorder that had been found in six people who had…

--

--

--

What matters now. A publication from Medium about politics, power, and culture.

Recommended from Medium

Asa critical care medicine specialist, I am used to seeing the sickest of the sick.

Advocacy for the Covid-19 Vaccine Should Start Now

55+ Living Centers

Vaccinating Fast is More Important Than Ever

Will Vaccines Work Against New Mutations?

COVID-19 reality in Mexico, Is the government lying?

Gene-Edited Mice Are Helping Coronavirus Research

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
James Surowiecki

James Surowiecki

I’m the author of The Wisdom of Crowds. I’ve been a business columnist for Slate and The New Yorker and written for a wide range of other publications.

More from Medium

How The New York Times Took the Fun Out of Wordle

Wordle and TikTok and the New Yorker, oh my!

Wordle: An Educational Perspective

The Face-Melting Joy of Your Team Winning a Championship